Crypto markets endured further pressure this week as the sell-off spread to some of the industry's largest digital asset treasuries (DATs). As of Friday, Bitcoin (BTC) had slipped back below $60,000 for the first time since 2024, Ethereum (ETH) was trading around $1,550, and Hyperliquid (HYPE) was near $57.
UK FCA issues warning on Hyperliquid over unauthorized services as crypto perpetual futures face growing regulatory scrutiny.
Grayscale Investments has filed with the U.S. Securities and Exchange Commission to launch a spot Canton Coin exchange-traded fund, extending its recent push into crypto investment products just days after its Hyperliquid staking ETF began trading.
The FCA's warning highlights the risks of using unregulated platforms, emphasizing the need for consumer protection in decentralized finance. Hyperliquid flagged by UK FCA as unauthorized firm targeting British users.
The warning from the UK's Financial Conduct Authority adds pressure to a perps market already under increasing scrutiny from regulators.
Hyperliquid has fallen sharply from its record high after a whale-led selloff triggered a wave of liquidations and pushed momentum indicators into their weakest position since the token's breakout rally began. According to data from crypto.
HYPE leads in price growth and perp trading volume, but Solana's larger token supply keeps its market cap firmly ahead.
Hyperliquid token has entered turbulence after one of crypto's strongest rallies suddenly reversed, with HYPE price plunging nearly 17% in a sharp selloff that caught traders off guard. The correction comes as fresh wallet movements linked to Arthur Hayes reignited fears of whale-driven profit-taking, adding pressure to an already overheated market structure.
Broadcom's disappointing AI chip outlook pulled the Nasdaq lower for a third session, dragged Asian equities down with it, and took crypto along for the ride.
Will SpaceX IPO debut boost some altcoins?
Arthur Hayes just hit the sell button really hard, sending shockwaves through the altocin market.
HYPE's uptrend survived the sell-off, but a key test now lies ahead.